Protective effects and mechanisms of mogroside v on LPS-induced acute lung injury in mice

Pharmaceutical Biology

Volumn 52, Issue 6, 2014, Pages 729-734

  Shi, Dongfang ^a,b   Zheng, Meizhu ^b   Wang, Yumeng ^b   Liu, Chunming ^b   Chen, Shan ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

^b CHANGCHUN NORMAL UNIVERSITY   (China)

Author keywords

Airway inflammation; ALI; LPS; Mogroside V

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MOGROSIDE V; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; LIPOPOLYSACCHARIDE; PROTECTIVE AGENT; TRITERPENE;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL TRANSFER; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESEARCH; DRUG STRUCTURE; DRY WEIGHT; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; INFLAMMATORY CELL; LEUKOCYTE; LUNG LAVAGE; LUNG PROTECTION; MOUSE; NONHUMAN; PROTECTION; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; PATHOLOGY; RANDOMIZATION; TOXICITY;

ACUTE LUNG INJURY; ANIMALS; FEMALE; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; PROTECTIVE AGENTS; RANDOM ALLOCATION; TRITERPENES;

EID: 84900797699     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2013.867451     Document Type: Article

References (26)

1. Agouridakis P, Kyriakou D, Alexandrakis MG, et al. (2002). The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome. Respir Res 3:25.
2. Bhatia M, Moochhala S. (2004). Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 202: 145-56. (Pubitemid 38208651)
3. Bosma K, Fanelli V, Ranieri VM. (2005). Acute respiratory distress syndrome: Update on the latest developments in basic and clinical research. Curr Opin Anaesthesiol 18:137-45. (Pubitemid 40523225)
4. Cribbs SK, Matthay MA, Martin GS. (2010). Stem cells in sepsis and acute lung injury. Crit Care Med 38:2379-85.
5. Di R, Huang MT, Ho CT. (2011). Anti-inflammatory activities of mogrosides from Momordica grosvenori in murine macrophages and a murine ear edema model. J Agric Food Chem 59:7474-81.
6. Dowdy DW, Eid MP, Dennison CR, et al. (2006). Quality of life after acute respiratory distress syndrome: A meta-analysis. Intensive Care Med 32:1115-24. (Pubitemid 44232405)
7. Fukunaga K, Kohli P, Bonnans C, et al. (2005). Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. J Immunol 174: 5033-9.
8. Goodman RB, Pugin J, Lee JS, Matthay MA. (2003). Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev 14: 523-35. (Pubitemid 37296025)
9. Greenberger PA. (2008). Immunologic lung disease. J Allergy Clin Immunol 121:S393-7.
10. Ingram Jr RH. (1995). Relationships among airway-parenchymal interactions, lung responsiveness, and inflammation in asthma. Giles F. Filley Lecture. Chest 107:148S-52S.
11. Ishii Y. (2011). Acute lung injury/acute respiratory distress syndrome: Progress in diagnosis and treatment topics. I: Pathogenesis and pathophysiology; II: Etiology and epidemiology. Nihon Naika Gakkai Zasshi 100:1522-8.
12. Ito K, Jazrawi E, Cosio B, et al. (2001). p65-Activated histone acetyltransferase activity is repressed by glucocorticoids: Mifepristone fails to recruit HDAC2 to the p65-HAT complex. J Biol Chem 276:30208-15.
13. Johnson ER, Matthay MA. (2010). Acute lung injury: Epidemiology, pathogenesis, and treatment. J Aerosol Med Pulm Drug Deliv 23: 243-52.
14. Karin M. (1999). The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J Biol Chem 274:27339-42.
15. Karin M, Ben-Neriah Y. (2000). Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity. Annu Rev Immunol 18:621-63. (Pubitemid 30365393)
16. McKay A, Leung BP, McInnes IB, et al. (2004). A novel antiinflammatory role of simvastatin in a murine model of allergic asthma. J Immunol 172:2903-8. (Pubitemid 38263676)
17. Moreno C, Merino J, Vazquez B, et al. (2004). Anti-inflammatory cytokines induce lipopolysaccharide tolerance in human monocytes without modifying toll-like receptor 4 membrane expression. Scand J Immunol 59:553-8. (Pubitemid 38789224)
18. Opitz B, van Laak V, Eitel J, Suttorp N. (2010). Innate immune recognition in infectious and noninfectious diseases of the lung. Am J Respir Crit Care Med 181:1294-309.
19. Qi XY, Chen WJ, Zhang LQ, Xie BJ. (2008). Mogrosides extract from Siraitia grosvenori scavenges free radicals in vitro and lowers oxidative stress, serum glucose, and lipid levels in alloxan-induced diabetic mice. Nutr Res 28:278-84.
20. Rubenfeld GD, Caldwell E, Peabody E, et al. (2005). Incidence and outcomes of acute lung injury. N Engl J Med 353:1685-93. (Pubitemid 41464707)
21. Saluk-Juszczak J, Wachowicz B. (2005). The proinflammatory activity of lipopolysaccharide. Postepy Biochem 51:280-7.
22. Shields CJ, Winter DC, Redmond HP. (2002). Lung injury in acute pancreatitis: Mechanisms, prevention, and therapy. Curr Opin Crit Care 8:158-63. (Pubitemid 36132687)
23. Szarka RJ, Wang N, Gordon L, et al. (1997). A murine model of pulmonary damage induced by lipopolysaccharide via intranasal instillation. J Immunol Methods 202:49-57. (Pubitemid 27104267)
24. Wright JG, Christman JW. (2003). The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: Implications for therapy. Am J Respir Med: Drugs Devices Other Interventions 2:211-19. (Pubitemid 36869436)
25. Yingkun N, Zhenyu W, Jing L, et al. (2013). Stevioside protects LPS-induced acute lung injury in mice. Inflammation 36:242-50.
26. Zhang X, Song K, Xiong H, et al. (2009). Protective effect of florfenicol on acute lung injury induced by lipopolysaccharide in mice. Int Immunopharmacol 9:1525-9.